These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9220552)

  • 1. Desmoplastic neurotropic melanoma.
    Tsao H; Sober AJ; Barnhill RL
    Semin Cutan Med Surg; 1997 Jun; 16(2):131-6. PubMed ID: 9220552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
    Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
    Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
    Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
    Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
    Kanik AB; Yaar M; Bhawan J
    J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoplastic melanoma: a diagnostic trap for the unwary.
    McCarthy SW; Scolyer RA; Palmer AA
    Pathology; 2004 Oct; 36(5):445-51. PubMed ID: 15370114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
    Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
    Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma.
    Harris GR; Shea CR; Horenstein MG; Reed JA; Burchette JL; Prieto VG
    Am J Surg Pathol; 1999 Jul; 23(7):786-94. PubMed ID: 10403301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collision of desmoplastic-neurotropic melanoma and squamous cell carcinoma on the lip.
    Falanga V; Chartier M; Butmarc J; Tibbetts L
    J Cutan Pathol; 2008 May; 35(5):473-6. PubMed ID: 18399808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous desmoplastic melanoma.
    Busam KJ
    Adv Anat Pathol; 2005 Mar; 12(2):92-102. PubMed ID: 15731577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoplastic malignant melanoma: diagnosis of early clinical lesions.
    Wharton JM; Carlson JA; Mihm MC
    Hum Pathol; 1999 May; 30(5):537-42. PubMed ID: 10333224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
    Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
    Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma.
    Soltani MH; Pichardo R; Song Z; Sangha N; Camacho F; Satyamoorthy K; Sangueza OP; Setaluri V
    Am J Pathol; 2005 Jun; 166(6):1841-50. PubMed ID: 15920168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
    Attis MG; Burchette JL; Selim MA; Pham T; Soler AP
    Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential.
    Wu H; Barusevicius A; Babb J; Klein-Szanto A; Godwin A; Elenitsas R; Gelfand JM; Lessin S; Seykora JT
    J Cutan Pathol; 2005 Feb; 32(2):125-30. PubMed ID: 15606670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Desmoplastic malignant melanoma. Clinical and histopathologic results of a study in 34 patients].
    Rütten A; Hügel H; Kutzner H; Schirren CG; Küchler A; Groth W
    Hautarzt; 1996 Jun; 47(6):447-53. PubMed ID: 8767660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.